Okyo Pharma Ltd. (OKYO)
NASDAQ · Healthcare
Okyo Pharma Ltd. Operating Income 2020–2025
Okyo Pharma Ltd. annual/quarterly operating income history and growth rate from 2020 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Okyo Pharma Ltd. annual operating income for 2025 was -7.1 M, a 54.97% decrease from 2024.
- Okyo Pharma Ltd. annual operating income for 2024 was -15.7 M, a 19.43% increase from 2023.
- Okyo Pharma Ltd. annual operating income for 2023 was -13.2 M, a 184.68% increase from 2022.
- Okyo Pharma Ltd. annual operating income for 2022 was -4.6 M.
No data available.
Okyo Pharma Ltd. Operating Income — FAQ
Okyo Pharma Ltd. (OKYO) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Okyo Pharma Ltd.'s operating income?
Okyo Pharma Ltd. (OKYO) reported operating income of -$7M for fiscal 2025.
Where can I see OKYO's operating income history?
The chart and table above show Okyo Pharma Ltd.'s operating income by year and by quarter, including the growth rate.